Leawell International Ltd was incorporated in 1993 with its base in Hong Kong, specializing in marketing and distribution of pharmaceutical, chemical raw materials, intermediates, pharmaceutical finished dosages and medical equipment in and out of China. Our company acts as the bridge for foreign companies of China in the Pharmaceutical Industry. Acting as an agent and distributor for API and finish formulation for various multinational famous pharmaceutical companies in countries such as Italy, Germany, Spain, Austria, Netherlands, France, Mexico, Slovenia, Korea, India, Taiwan, etc. For these API and F/F, we have obtained 98 Import Drug Licenses. Among them, 45 items of which we registered and act as agent; 34 items are under application by us. Presently, we submitte an average of 10 import drug applications every year. We have a group of specialists working on registration from the very start: market survey, translation, communication, quality feedback, importation, following up and reviewing of dossier according to the Chinese Registering Rule, inspecting of samples, exchanging views with CDE reviewers, etc. Lately, we have signed agreements with several esteemed Chinese manufacturers on 19 projects, which link our API IDL application with their F/F manufacturing license application. In the meantime, we have 6 projects on finished formulation IDL application, and many projects are under discussions. At the same time, we are also active in exporting API and Intermediates to Europe, and also helping local manufacturers for DMF and COS registration. Recently, Guangzhou Baiyunshan Pharmaceutical has authorized us as an exclusive agent for handling import and export for the European manufacturers. We actively promote Chinese manufactured pharmaceuticals and are renowned in China for antibiotics and the import and export business. We established a Joint Venture in Shantou in 2002 – Shantou Antibiotics Pharmaceutical Co. Ltd., producing antibiotics API. We are not only an cooperation with many esteemed pharmaceutical manufacturers in mainland China, but also acting as an agent of sales and registration for them to help the Chinese pharmaceutical companies in registration of their Chinese medicine products in Hong Kong. Leawell has established an extensive and long-term cooperation relationship with the pharmaceutical companies and manufacturers in and out of China. We are experienced in scale production of a variety of sterile product dosage forms, including sterile injection powder, injection, tablets, capsules, suppository, ointments, eye-drop, etc. We are also experienced in processing the pharmaceutical and chemical raw materials and intermediates in and out of China. Our subsidiary, Guangdong Leawell Pharmaceutical Co. Ltd., owns operation licenses for all types of API, finished dosages and medical equipments with GSP certificate. While our subsidiary in Beijing, Beijing Century Leawell Pharmaceutical Development Ltd, is responsible for the IDL, COS and DMF applications and technical consultation. We also have a subsidiary in Shanghai, which is responsible for the export. Over the past 15 years, Leawell has established an extensive and long-term cooperation relationship with hundreds of reputable pharmaceutical companies and manufacturers in China and all over the world.